{"organizations": [], "uuid": "59c8447a9681970590e1ca28907959f1c134df3a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-karyopharms-selinexor-receives-fas/brief-karyopharms-selinexor-receives-fast-track-designation-from-fda-idUSASC09VDB", "country": "US", "domain_rank": 408, "title": "BRIEF-Karyopharm's Selinexor Receives Fast Track Designation From FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T14:26:00.000+03:00", "replies_count": 0, "uuid": "59c8447a9681970590e1ca28907959f1c134df3a"}, "author": "", "url": "https://www.reuters.com/article/brief-karyopharms-selinexor-receives-fas/brief-karyopharms-selinexor-receives-fast-track-designation-from-fda-idUSASC09VDB", "ord_in_thread": 0, "title": "BRIEF-Karyopharm's Selinexor Receives Fast Track Designation From FDA", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "karyopharm therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 27 AM / Updated 12 minutes ago BRIEF-Karyopharm's Selinexor Receives Fast Track Designation From FDA Reuters Staff 1 Min Read \nApril 10 (Reuters) - Karyopharm Therapeutics Inc: \n* KARYOPHARMâ€™S SELINEXOR RECEIVES FAST TRACK DESIGNATION FROM FDA FOR THE TREATMENT OF PATIENTS WITH PENTA-REFRACTORY MULTIPLE MYELOMA \n* EXPECTS TO REPORT TOP-LINE DATA FROM STORM STUDY AT END OF APRIL 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-10T14:26:00.000+03:00", "crawled": "2018-04-10T14:45:47.015+03:00", "highlightTitle": ""}